Tue, April 12, 2022

Ami Fadia Maintained (BCYC) at Strong Buy with Decreased Target to $75 on, Apr 12th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-75-on-apr-12th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Ami Fadia of Needham, Maintained "Bicycle Therapeutics plc" (BCYC) at Strong Buy with Decreased Target from $85 to $75 on, Apr 12th, 2022.

Ami has made no other calls on BCYC in the last 4 months.



There are 3 other peers that have a rating on BCYC. Out of the 3 peers that are also analyzing BCYC, 1 agrees with Ami's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Initiated at Hold and Held Target at $60 on, Monday, February 14th, 2022


These are the ratings of the 2 analyists that currently disagree with Ami


  • Reni Benjamin of "JMP Securities" Maintained at Buy with Decreased Target to $70 on, Thursday, March 3rd, 2022
  • Jonathan Chang of "SVB Leerink" Initiated at Buy and Held Target at $70 on, Friday, December 17th, 2021